ASTELLAS PHARMA INC : Astellas Announces Acceptance of U.S. New Drug ... 4-traders Drug Administration (FDA) has accepted for review the company's New Drug Application (NDA) for tacrolimus extended release capsules, for the prophylaxis of organ rejection in adult kidney transplant recipients and adult male liver transplant recipients. |
